Osaic Holdings’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
Other funds holding GYRE
Osaic Holdings's GYRE Position: Q3 2026 in Review
Osaic Holdings reduced its Gyre Therapeutics (GYRE) stake by 14% in Q3 2026, selling an estimated $40 and leaving 38 shares worth $278. The position accounts for ﹤0.01% of the portfolio, ranked #7813.
Osaic Holdings first reported a position in GYRE in Q4 2022 and has held it in 16 quarters since. The position peaked at $7.65K in Q2 2024. 58 funds tracked by Wall St. Rank hold GYRE as of Q3 2026.
- Osaic Holdings held 38 shares of Gyre Therapeutics worth $278 as of Q3 2026.
- Osaic Holdings sold 6 Gyre Therapeutics shares in Q3 2026, an estimated $40.
- Gyre Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7813 holding.
- Osaic Holdings first reported a position in Gyre Therapeutics in Q4 2022 and has held it in 16 quarters since.
- Osaic Holdings's Gyre Therapeutics position peaked at $7.65K in Q2 2024.
- 58 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.